Compile Data Set for Download or QSAR
Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 13014
TargetPeroxisome proliferator-activated receptor gamma(Human)
Cureverse

US Patent
LigandPNGBDBM751468(US20250197363, Example 1)
Affinity DataEC50:  39.9nMAssay Description:In order to confirm the PPARδ activation effect of the example compounds, the following experiment was performed. First, the example compounds were d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Cureverse

US Patent
LigandPNGBDBM751486(US20250197363, Example 25)
Affinity DataEC50:  42nMAssay Description:In order to confirm the PPARδ activation effect of the example compounds, the following experiment was performed. First, the example compounds were d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Cureverse

US Patent
LigandPNGBDBM751480(US20250197363, Example 19)
Affinity DataEC50:  289nMAssay Description:In order to confirm the PPARδ activation effect of the example compounds, the following experiment was performed. First, the example compounds were d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Cureverse

US Patent
LigandPNGBDBM751471(US20250197363, Example 3)
Affinity DataEC50:  374nMAssay Description:In order to confirm the PPARδ activation effect of the example compounds, the following experiment was performed. First, the example compounds were d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Cureverse

US Patent
LigandPNGBDBM751470(US20250197363, Example 2)
Affinity DataEC50:  420nMAssay Description:In order to confirm the PPARδ activation effect of the example compounds, the following experiment was performed. First, the example compounds were d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Cureverse

US Patent
LigandPNGBDBM751472(US20250197363, Example 8)
Affinity DataEC50:  504nMAssay Description:In order to confirm the PPARδ activation effect of the example compounds, the following experiment was performed. First, the example compounds were d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Cureverse

US Patent
LigandPNGBDBM751483(US20250197363, Example 22)
Affinity DataEC50:  574nMAssay Description:In order to confirm the PPARδ activation effect of the example compounds, the following experiment was performed. First, the example compounds were d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Cureverse

US Patent
LigandPNGBDBM751488(US20250197363, Example 27)
Affinity DataEC50:  595nMAssay Description:In order to confirm the PPARδ activation effect of the example compounds, the following experiment was performed. First, the example compounds were d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Cureverse

US Patent
LigandPNGBDBM751474(US20250197363, Example 12)
Affinity DataEC50:  663nMAssay Description:In order to confirm the PPARδ activation effect of the example compounds, the following experiment was performed. First, the example compounds were d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Cureverse

US Patent
LigandPNGBDBM751487(US20250197363, Example 26)
Affinity DataEC50:  1.24E+3nMAssay Description:In order to confirm the PPARδ activation effect of the example compounds, the following experiment was performed. First, the example compounds were d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Cureverse

US Patent
LigandPNGBDBM751485(US20250197363, Example 24)
Affinity DataEC50:  1.25E+3nMAssay Description:In order to confirm the PPARδ activation effect of the example compounds, the following experiment was performed. First, the example compounds were d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Cureverse

US Patent
LigandPNGBDBM751478(US20250197363, Example 16)
Affinity DataEC50:  1.35E+3nMAssay Description:In order to confirm the PPARδ activation effect of the example compounds, the following experiment was performed. First, the example compounds were d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Cureverse

US Patent
LigandPNGBDBM751476(US20250197363, Example 14)
Affinity DataEC50:  2.10E+3nMAssay Description:In order to confirm the PPARδ activation effect of the example compounds, the following experiment was performed. First, the example compounds were d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Cureverse

US Patent
LigandPNGBDBM751479(US20250197363, Example 18)
Affinity DataEC50:  2.21E+3nMAssay Description:In order to confirm the PPARδ activation effect of the example compounds, the following experiment was performed. First, the example compounds were d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Cureverse

US Patent
LigandPNGBDBM751481(US20250197363, Example 20)
Affinity DataEC50:  2.36E+3nMAssay Description:In order to confirm the PPARδ activation effect of the example compounds, the following experiment was performed. First, the example compounds were d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Cureverse

US Patent
LigandPNGBDBM751473(US20250197363, Example 9)
Affinity DataEC50:  2.44E+3nMAssay Description:In order to confirm the PPARδ activation effect of the example compounds, the following experiment was performed. First, the example compounds were d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Cureverse

US Patent
LigandPNGBDBM751482(US20250197363, Example 21)
Affinity DataEC50:  2.66E+3nMAssay Description:In order to confirm the PPARδ activation effect of the example compounds, the following experiment was performed. First, the example compounds were d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Cureverse

US Patent
LigandPNGBDBM751477(US20250197363, Example 15)
Affinity DataEC50:  4.01E+3nMAssay Description:In order to confirm the PPARδ activation effect of the example compounds, the following experiment was performed. First, the example compounds were d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Cureverse

US Patent
LigandPNGBDBM751484(US20250197363, Example 23)
Affinity DataEC50:  5.70E+3nMAssay Description:In order to confirm the PPARδ activation effect of the example compounds, the following experiment was performed. First, the example compounds were d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Cureverse

US Patent
LigandPNGBDBM751475(US20250197363, Example 13)
Affinity DataEC50:  6.16E+3nMAssay Description:In order to confirm the PPARδ activation effect of the example compounds, the following experiment was performed. First, the example compounds were d...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/14/2025
Entry Details
Go to US Patent